{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:53:27Z","timestamp":1780066407968,"version":"3.54.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["No. pumch201911390"],"award-info":[{"award-number":["No. pumch201911390"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["2022-PUMCH-B-120"],"award-info":[{"award-number":["2022-PUMCH-B-120"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["2022-PUMCH-B-070"],"award-info":[{"award-number":["2022-PUMCH-B-070"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 12205329"],"award-info":[{"award-number":["No. 12205329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 12175268"],"award-info":[{"award-number":["No. 12175268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011181","name":"Institute of High Energy Physics, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["No. E4545AU21"],"award-info":[{"award-number":["No. E4545AU21"]}],"id":[{"id":"10.13039\/501100011181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00415-024-12874-4","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T13:04:54Z","timestamp":1736946294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patterns of Tau pathology in patients with anti-IgLON5 disease visualized by Florzolotau (18F) PET"],"prefix":"10.1007","volume":"272","author":[{"given":"Siyuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujun","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"12874_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamaria J, Dalmau J, Graus F (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586","journal-title":"Lancet Neurol"},{"key":"12874_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, Hoftberger R, Graus F, Ling H, Holton JL, Dawson T, Popovic M, Pretnar-Oblak J, Hogl B, Schmutzhard E, Poewe W, Ricken G, Santamaria J, Dalmau J, Budka H, Revesz T, Kovacs GG (2016) Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 132:531\u2013543","journal-title":"Acta Neuropathol"},{"key":"12874_CR3","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1093\/brain\/awae048","volume":"147","author":"SM Yogeshwar","year":"2024","unstructured":"Yogeshwar SM, Mu\u00f1iz-Castrillo S, Sabater L, Peris-Sempere V, Mallajosyula V, Luo G, Yan H, Yu E, Zhang J, Lin L, Fagundes Bueno F, Ji X, Picard G, Rogemond V, Pinto AL, Heidbreder A, H\u00f6ftberger R, Graus F, Dalmau J, Santamaria J, Iranzo A, Schreiner B, Giannoccaro MP, Liguori R, Shimohata T, Kimura A, Ono Y, Binks S, Mariotto S, Dinoto A, Bonello M, Hartmann CJ, Tambasco N, Nigro P, Pr\u00fcss H, McKeon A, Davis MM, Irani SR, Honnorat J, Gaig C, Finke C, Mignot E (2024) HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease. Brain 147:2579\u20132592","journal-title":"Brain"},{"key":"12874_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","volume":"146","author":"E Berger-Sieczkowski","year":"2023","unstructured":"Berger-Sieczkowski E, Endmayr V, Haider C, Ricken G, Jauk P, Macher S, Pirker W, H\u00f6gl B, Heidbreder A, Schnider P, Bradley-Zechmeister E, Mariotto S, Koneczny I, Reinecke R, Kasprian G, Weber C, Bergmann M, Milenkovic I, Berger T, Gaig C, Sabater L, Graus F, Gelpi E, H\u00f6ftberger R (2023) Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease. Acta Neuropathol 146:631\u2013645","journal-title":"Acta Neuropathol"},{"key":"12874_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000651","volume":"7","author":"ME Erro","year":"2020","unstructured":"Erro ME, Sabater L, Martinez L, Herrera M, Ostolaza A, Garcia de Gurtubay I, Tunon T, Graus F, Gelpi E (2020) Anti-IGLON5 disease: a new case without neuropathologic evidence of brainstem tauopathy. Neurol Neuroimmunol Neuroinflamm 7:e651","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12874_CR6","doi-asserted-by":"publisher","first-page":"e1367","DOI":"10.1212\/WNL.0000000000012639","volume":"97","author":"C Gaig","year":"2021","unstructured":"Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y, Hogl B, Lewerenz J, Erro ME, Garcia-Monco JC, Nigro P, Tambasco N, Patalong-Ogiewa M, Erdler M, Macher S, Berger-Sieczkowski E, Hoftberger R, Geis C, Hutterer M, Milan-Tomas A, Martin-Bastida A, Manzanares LL, Quintas S, Hoglinger GU, Mohn N, Schoeberl F, Thaler FS, Asioli GM, Provini F, Plazzi G, Berganzo K, Blaabjerg M, Bruggemann N, Farias T, Ng CF, Giordana C, Herrero-San Martin A, Huebra L, Kotschet K, Liendl H, Montojo T, Morata C, Perez JP, Puertas I, Seifert-Held T, Seitz C, Simabukuro MM, Tellez N, Villacieros-Alvarez J, Willekens B, Sabater L, Iranzo A, Cano JS, Dalmau J, Graus F (2021) Frequency and characterization of movement disorders in anti-IgLON5 disease. Neurology 97:e1367\u2013e1381","journal-title":"Neurology"},{"key":"12874_CR7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, Hogl B, Bataller L, Bruggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Marti MJ, Montojo T, Perez-Perez J, Puertas I, Seitz C, Simabukuro M, Tellez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaria J, Dalmau J (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743","journal-title":"Neurology"},{"key":"12874_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu KM, Yang L, Dong Q, Yu JT (2022) Tauopathies: new perspectives and challenges. Mol Neurodegener 17:28","journal-title":"Mol Neurodegener"},{"key":"12874_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/jnnp-2021-328586","volume":"93","author":"S Koga","year":"2022","unstructured":"Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW (2022) Neuropathology and emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatry 93:919\u2013929","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12874_CR10","doi-asserted-by":"publisher","first-page":"e2325","DOI":"10.1212\/WNL.0000000000207870","volume":"101","author":"H Theis","year":"2023","unstructured":"Theis H, Bischof GN, Br\u00fcggemann N, Dargvainiene J, Drzezga A, Gr\u00fcter T, Lewerenz J, Leypoldt F, Neumaier B, Wandinger KP, Ayzenberg I, van Eimeren T (2023) In vivo measurement of Tau depositions in anti-IgLON5 disease using [18F]PI-2620 PET. Neurology 101:e2325\u2013e2330","journal-title":"Neurology"},{"key":"12874_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1212\/WNL.0000000000005859","volume":"91","author":"F Schoberl","year":"2018","unstructured":"Schoberl F, Levin J, Remi J, Goldschagg N, Eren O, Okamura N, Unterrainer M, Rominger A, Albert N, Brendel M (2018) IgLON5: a case with predominant cerebellar tau deposits and leptomeningeal inflammation. Neurology 91:180\u2013182","journal-title":"Neurology"},{"key":"12874_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/RLU.0000000000003164","volume":"45","author":"JL Hsu","year":"2020","unstructured":"Hsu JL, Lin KJ, Hsiao IT, Huang KL, Liu CH, Wu HC, Weng YC, Huang CY, Chang CC, Yen TC, Higuchi M, Jang MK, Huang CC (2020) The imaging features and clinical associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer disease. Clin Nucl Med 45:747\u2013756","journal-title":"Clin Nucl Med"},{"key":"12874_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","volume":"109","author":"K Tagai","year":"2021","unstructured":"Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y, Matsuoka K, Takuwa H, Shimojo M, Takahashi M, Kawamura K, Kikuchi T, Okada M, Akiyama H, Suzuki H, Onaya M, Takeda T, Arai K, Arai N, Araki N, Saito Y, Trojanowski JQ, Lee VMY, Mishra SK, Yamaguchi Y, Kimura Y, Ichise M, Tomita Y, Zhang MR, Suhara T, Shigeta M, Sahara N, Higuchi M, Shimada H (2021) High-contrast in vivo imaging of Tau pathologies in Alzheimer\u2019s and Non-Alzheimer\u2019s disease tauopathies. Neuron 109:42-58.e48","journal-title":"Neuron"},{"key":"12874_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","volume":"50","author":"FT Liu","year":"2023","unstructured":"Liu FT, Lu JY, Li XY, Liang XN, Jiao FY, Ge JJ, Wu P, Li G, Shen B, Wu B, Sun YM, Zhu YH, Luo JF, Yen TC, Wu JJ, Zuo CT, Wang J (2023) (18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging 50:1395\u20131405","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12874_CR15","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00259-022-05752-6","volume":"49","author":"T Zhang","year":"2022","unstructured":"Zhang T, Nie B, Liu H, Shan B (2022) Unified spatial normalization method of brain PET images using adaptive probabilistic brain atlas. Eur J Nucl Med Mol Imaging 49:3073\u20133085","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12874_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","volume":"19","author":"JA Maldjian","year":"2003","unstructured":"Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233\u20131239","journal-title":"Neuroimage"},{"key":"12874_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41181-024-00259-x","volume":"9","author":"KJ Lin","year":"2024","unstructured":"Lin KJ, Huang SY, Huang KL, Huang CC, Hsiao IT (2024) Human biodistribution and radiation dosimetry for the tau tracer [(18)F]Florzolotau in healthy subjects. EJNMMI Radiopharm Chem 9:27","journal-title":"EJNMMI Radiopharm Chem"},{"key":"12874_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06923-3","author":"FT Liu","year":"2024","unstructured":"Liu FT, Lu JY, Li XY, Ge JJ, Sun YM, Yen TC, Jiao FY, Chen MJ, Zhao J, Yao RX, Tang G, Xu H, Lan XL, Lu J, Cui RX, Brendel M, Shi K, Guan YH, Rominger A, Wang J, Zuo CT (2024) Visual reading for [(18)F]Florzolotau Tau PET scans in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-024-06923-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12874_CR19","doi-asserted-by":"crossref","unstructured":"Gruter T, Mollers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, Kraft A, Hoftberger R, Schoberl F, Thaler FS, Wickel J, Chung HY, Seifert F, Tschernatsch M, Nagel M, Lewerenz J, Jarius S, Wildemann BC, de Azevedo L, Heidenreich F, Heusgen R, Hofstadt-van Oy U, Linsa A, Maass JJ, Menge T, Ringelstein M, Pedrosa DJ, Schill J, Seifert-Held T, Seitz C, Tonner S, Urbanek C, Zittel S, Markewitz R, Korporal-Kuhnke M, Schmitter T, Finke C, Bruggemann N, Bien CI, Kleiter I, Gold R, Wandinger KP, Kuhlenbaumer G, Leypoldt F, Ayzenberg I, German Network for Research on Autoimmune E (2023) Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain 146:600\u2013611","DOI":"10.1093\/brain\/awac090"},{"key":"12874_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/RLU.0000000000001339","volume":"41","author":"W Zhang","year":"2016","unstructured":"Zhang W, Niu N, Cui R (2016) Serial 18F-FDG PET\/CT findings in a patient with IgLON5 encephalopathy. Clin Nucl Med 41:787\u2013788","journal-title":"Clin Nucl Med"},{"key":"12874_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/ene.15117","volume":"29","author":"Y Ni","year":"2022","unstructured":"Ni Y, Shen D, Zhang Y, Song Y, Gao Y, Zhou Q, He L, Yin D, Wang Y, Song F, Chen M, Lian Y, Chen Y, Zhao X, Zhang X, Chen X, Wang Y, Zhang L, Mo N, Lv D, Liu J, Mao Z, Peng L, Chen S (2022) Expanding the clinical spectrum of anti-IgLON5 disease: a multicenter retrospective study. Eur J Neurol 29:267\u2013276","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12874-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12874-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12874-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:41:00Z","timestamp":1739637660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12874-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12874"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12874-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors involved in this work have declared no conflicts of interest. Tzu-Chen Yen is an employee and shareholder of APRINOIA Therapeutics Co, Ltd, Suzhou, China. And the precursor was provided by APRINOIA Therapeutics Co, Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"115"}}